Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Joy

Showing results (71-80 of 185) with videos related to

Pageof 19
Sort By:
Toxicology Reports|September 30, 2017
Nrf2 activators as potential modulators of injury in human kidney cellsAmandla Atilano-Roque, Xia Wen, Lauren M Aleksunes, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2024
Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studiesRaymond E West, Junmei Zhang, Melanie S Joy, et al.
The International Journal of Social Psychiatry|August 1, 2017
Explanatory models and distress in primary caregivers of patients with acute psychotic presentations: A study from South IndiaDeepa S Joy, S D Manoranjitham, P Samuel, et al.
Frontiers in Endocrinology|December 26, 2022
Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetesKhalid Siddiqui, Teena P George, Salini S Joy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysisM S Joy, G R Matzke, R F Frye, et al.
European Journal of Clinical Pharmacology|November 2, 2015
A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS)David Ternant, Gilles Paintaud, Howard Trachtman, et al.
Pharmacotherapy|June 15, 2000
Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysisG R Matzke, R F Frye, M S Joy, et al.
Journal of Wildlife Diseases|April 10, 2013
Feline infectious peritonitis in a mountain lion (Puma concolor), California, USANicole Stephenson, Pamela Swift, Robert B Moeller, et al.
Molecular Biology of the Cell|May 22, 1998
Effect of carbohydrate position on lysosomal transport of procathepsin LR G Lingeman, D S Joy, M A Sherman, et al.
International Journal of General Medicine|May 17, 2014
Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney diseaseKaty E Trinkley, S Michelle Nikels, Robert L Page, et al.
Pageof 19

Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Toxicology Reports|September 30, 2017
Nrf2 activators as potential modulators of injury in human kidney cellsAmandla Atilano-Roque, Xia Wen, Lauren M Aleksunes, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 4, 2024
Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studiesRaymond E West, Junmei Zhang, Melanie S Joy, et al.
The International Journal of Social Psychiatry|August 1, 2017
Explanatory models and distress in primary caregivers of patients with acute psychotic presentations: A study from South IndiaDeepa S Joy, S D Manoranjitham, P Samuel, et al.
Frontiers in Endocrinology|December 26, 2022
Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetesKhalid Siddiqui, Teena P George, Salini S Joy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysisM S Joy, G R Matzke, R F Frye, et al.
European Journal of Clinical Pharmacology|November 2, 2015
A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS)David Ternant, Gilles Paintaud, Howard Trachtman, et al.
Pharmacotherapy|June 15, 2000
Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysisG R Matzke, R F Frye, M S Joy, et al.
Journal of Wildlife Diseases|April 10, 2013
Feline infectious peritonitis in a mountain lion (Puma concolor), California, USANicole Stephenson, Pamela Swift, Robert B Moeller, et al.
Molecular Biology of the Cell|May 22, 1998
Effect of carbohydrate position on lysosomal transport of procathepsin LR G Lingeman, D S Joy, M A Sherman, et al.
International Journal of General Medicine|May 17, 2014
Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney diseaseKaty E Trinkley, S Michelle Nikels, Robert L Page, et al.
Pageof 19